Related Experiment Video
Updated: Aug 13, 2026

A Middle Cerebral Artery Occlusion Technique for Inducing Post-stroke Depression in Rats
Published on: May 22, 2019
miR-22 and cerebral microbleeds in brainstem and deep area are associated with depression one month after ischemic
Jia Hu1, Wei Zhou2, Zhiming Zhou3
1Department of Neurology, First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.
Abstract:
In this study, we aimed to explore the relationship among miR-22, deep cerebral microbleeds (CMBs), and post-stroke depression (PSD) 1 month after ischemic stroke. We consecutively recruited 257 patients with first-ever and recurrent acute cerebral infarction and performed PSD diagnosis in accordance with the Diagnostic and Statistical Manual IV criteria for depression. Clinical information, assessments of stroke severity, and imaging data were recorded on admission. We further detected plasma miR-22 using quantitative PCR and analyzed the relationship among miR-22, clinical data, and PSD using SPSS 23.0 software. Logistic regression showed that deep (OR=1.845, 95%CI: 1.006-3.386, P=0.047) and brain stem CMBs (OR=2.652, 95%CI: 1.110-6.921, P=0.040), as well as plasma miR-22 levels (OR=2.094, 95%CI: 1.066-4.115, P=0.032) were independent risk factors for PSD. In addition, there were significant differences in baseline National Institutes of Health Stroke Scale scores (OR=1.881, 95%CI: 1.180-3.011, P=0.007) and Widowhood scores (OR=1.903, 95%CI: 1.182-3.063, P=0.012). Analysis of the receiver operating curve (AUC=0.723, 95%CI: 0.562-0.883, P=0.016) revealed that miR-22 could predict PSD one month after ischemic stroke. Furthermore, plasma miR-22 levels in brainstem and deep CMBs patients showed an upward trend (P=0.028) relative to the others. Patients with acute ischemic stroke, having brainstem and deep cerebral microbleeds, or a higher plasma miR-22 were more likely to develop PSD. These findings indicate that miR-22 might be involved in cerebral microvascular impairment and post-stroke depression.
Insights
Higher plasma miR-22 levels and deep or brainstem cerebral microbleeds (CMBs) are independent risk factors for post-stroke depression (PSD) one month after ischemic stroke. miR-22 may predict PSD development and is linked to cerebral microvascular impairment.
Area of Science:
- Neuroscience
- Biochemistry
- Genetics
Background:
- Post-stroke depression (PSD) is a common complication following ischemic stroke, significantly impacting patient recovery and quality of life.
- Cerebral microbleeds (CMBs), particularly deep and brainstem microbleeds, are increasingly recognized as potential contributors to neurological and psychological deficits after stroke.
- MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression and are implicated in various biological processes, including neurological disorders.
Purpose of the Study:
- To investigate the association between plasma miR-22 levels, the presence of deep and brainstem CMBs, and the occurrence of PSD one month after acute ischemic stroke.
- To identify independent risk factors for PSD in patients with acute cerebral infarction.
- To evaluate the predictive value of plasma miR-22 for PSD development.
Main Methods:
- A cohort of 257 patients with first-ever or recurrent acute cerebral infarction were recruited.
- Diagnosis of PSD was performed using the Diagnostic and Statistical Manual IV criteria.
- Plasma miR-22 levels were quantified using quantitative PCR, and associations with clinical data, CMBs, and PSD were analyzed using logistic regression and receiver operating curve analysis.
Main Results:
- Deep CMBs (OR=1.845) and brainstem CMBs (OR=2.652) were identified as independent risk factors for PSD.
- Elevated plasma miR-22 levels (OR=2.094) were also found to be an independent risk factor for PSD.
- Receiver operating curve analysis indicated that miR-22 has predictive value for PSD (AUC=0.723, P=0.016).
- Plasma miR-22 levels showed an upward trend in patients with brainstem and deep CMBs (P=0.028).
Conclusions:
- Plasma miR-22 levels and the presence of deep or brainstem CMBs are significant independent risk factors for developing PSD one month post-ischemic stroke.
- miR-22 may play a role in the pathophysiology of cerebral microvascular impairment and PSD.
- These findings suggest miR-22 as a potential biomarker for predicting PSD in stroke patients.
Related Concept Videos
Ischemic Stroke l: Introduction
Ischemic Stroke ll: Pathophysiology
Transient Ischemic Attack l: Introduction

